Related Experiment Videos
Cardiovascular outcomes for obesity and metabolic syndrome
1Department of Clinical Nutrition, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-9052, USA. Gloria.Vega@utsouthwestern.edu
Obesity Research
|November 26, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Statin therapy for primary prevention in women: What is the role for coronary artery calcium?
Journal of clinical lipidology·2022
Utility of metabolic syndrome as a risk enhancing factor in decision of statin use.
Journal of clinical lipidology·2021
Chronic kidney disease and statin eligibility.
Journal of clinical lipidology·2020
Coronary and peripheral artery plaques: do differences in plaque characteristics translate to differences in lipid management?
Journal of investigative medicine : the official publication of the American Federation for Clinical Research·2020
Traditional signs and symptoms commonly attributed to hypogonadism do not correlate with testosterone levels: the Cooper Center Longitudinal Study Experience.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research·2019
Gastric bypass as treatment for obesity: trends, characteristics, and complications.
Obesity research·2006
Predictors of long-term weight maintenance.
Obesity research·2006
SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Managing Metabolic Syndrome Among Patients with Type 2 Diabetes Mellitus - A Narrative Review.
Cardiovascular & hematological disorders drug targets·2026
LncRNA HIF1A-AS3 Promotes Glycolysis and Regulates Metabolic Reprogramming in Human Mesenchymal Stem Cells.
Current stem cell research & therapy·2026
Mitochondrial Dynamics and Bioenergetic Reprogramming: Drivers of Cancer Therapy Resistance.
Mini reviews in medicinal chemistry·2026